Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2012
07/11/2012CN102558351A Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof
07/11/2012CN102558350A Anti-ovalbumin monoclonal antibody and preparation method thereof
07/11/2012CN102558349A Monoclonal antibody capable of recognizing natural-structure sika prion and preparation method
07/11/2012CN102558348A Single-chain antibody for resisting influenza viruses, preparation method for single-chain antibody, application of single-chain antibody
07/11/2012CN102558347A Yolk antibody for treating bird flu and infectious bronchitis and preparation method thereof
07/11/2012CN102558346A Monoclonal antibody anti-phiX174 phage splitting protein E, hybridoma cell strain producing antibody and epitope thereof
07/11/2012CN102558341A Porcine CD28 receptor and coding gene and application thereof
07/11/2012CN102558336A PRR11 gene and coded protein and application thereof
07/11/2012CN102558334A Peptides that selectively home to heart vasculature and related conjugates and methods
07/11/2012CN102558318A A mutated immunoglobulin-binding protein
07/11/2012CN102558317A A mutated immunoglobulin-binding protein
07/11/2012CN102558315A Staphylococcal protein A, preparation method thereof and use thereof
07/11/2012CN102558313A Enterovirus 71 type specific recombinant protein antigen and application thereof
07/11/2012CN102558306A Antigen epitope for preventing and treating trichinosis, composition thereof and application thereof
07/11/2012CN102558001A Improved processes for making hydrazides
07/11/2012CN102553297A Preparation and application of miniature high-efficiency clenbuterol immuno-affinity chromatography column
07/11/2012CN102552905A Cd40 antibody formulation and methods
07/11/2012CN102552306A Method for treating septicemia with human neutrophil peptide (HNP) blocking agents
07/11/2012CN101798348B Anti-uPAR humanized antibody and application thereof
07/11/2012CN101591391B Enterovirus 71 type human immunoglobulin and preparation method thereof
07/11/2012CN101054417B Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
07/10/2012US8217158 Immunotoxin fusion proteins and means for expression thereof
07/10/2012US8217153 Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents
07/10/2012US8217150 Toxin detection method
07/10/2012US8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
07/10/2012US8217148 c-Met antibodies
07/10/2012US8217147 Recombinant immunoglobulins to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy
07/10/2012US8216805 Knobs and holes heteromeric polypeptides
07/10/2012US8216794 Extracellular serine protease
07/10/2012US8216586 Lipases and uses thereof
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216583 Formulation of human antibodies for treating TNF-α associated disorders
07/10/2012US8216581 Using competitive cell surface panning to identify cells expressing preferential monoclonal antibodies; diagnosis and treatment of thrombocytopenia; thrombolytic agent
07/10/2012US8216580 Sulfatases and methods of use thereof
07/10/2012US8216577 Anti-Aβ antibodies and their use
07/10/2012US8216576 Method for inhibiting binding to B-cell receptor
07/10/2012US8216574 Engineering Fc antibody regions to confer effector function
07/10/2012US8216572 Antibody therapy
07/10/2012US8216571 Fully human anti-VEGF antibodies and methods of using
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012CA2632828C Antibodies against amyloid beta with glycosylation in the variable region
07/10/2012CA2557229C A method of providing a purified, virus safe antibody preparation
07/10/2012CA2532117C Humanized immunoglobulin loci
07/10/2012CA2520010C Gastrin hormone immunoassays
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2382336C Vaccines from infectious agents
07/10/2012CA2340790C Human il-1 epsilon dna and polypeptides
07/10/2012CA2326499C Methods of selecting internalizing antibodies
07/10/2012CA2306450C Polypeptides and nucleic acids encoding same
07/10/2012CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor
07/05/2012WO2012092616A1 Conjugated anti-cd38 antibodies
07/05/2012WO2012092612A1 Anti-cd38 antibodies
07/05/2012WO2012092539A2 Antibodies to dll4 and uses thereof
07/05/2012WO2012092531A1 Her3 protein srm/mrm assay
07/05/2012WO2012092376A2 Comprehensive monoclonal antibody generation
07/05/2012WO2012092374A2 Express humanization of antibodies
07/05/2012WO2012092175A1 Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor
07/05/2012WO2012091564A2 A cross-linking polypeptide that induces apoptosis
07/05/2012WO2012091563A1 A polypeptide that binds aberrant cells and induces apoptosis
07/05/2012WO2012091465A2 Monoclonal antibodies to serum amyloid a, and hybridoma cells producing same
07/05/2012WO2012091138A1 Diagnostic drug and diagnostic method for alzheimer's disease
07/05/2012WO2012090895A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same
07/05/2012WO2012089814A1 Antigen binding formats for use in therapeutic treatments or diagnostic assays
07/05/2012WO2012089778A1 Pharmaceutical formulation comprising a biopharmaceutical drug
07/05/2012WO2012089176A1 Recombinant antibodies to the vascular endothelial growth factor (vegf) which are obtained by means of mutagenesis of variable regions
07/05/2012WO2012064836A9 Methods and compositions for neural disease immunotherapy
07/05/2012WO2012062810A3 Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
07/05/2012WO2012059928A3 Antivenom
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012WO2012021475A3 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
07/05/2012WO2012018404A3 Use of her3 binding agents in prostate treatment
07/05/2012WO2011163478A4 Dual variable domain immunoglobulins and uses thereof
07/05/2012WO2011110642A3 Monoclonal antibodies against c-met
07/05/2012US20120174264 Uses of Yerba Santa
07/05/2012US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof
07/05/2012US20120172578 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
07/05/2012US20120171747 Signal amplification microspheres, their use in one-step and multi-step analytical amplification procedures and methods for their production
07/05/2012US20120171701 Identification of regulatory t cells via the global gene regulator satb1
07/05/2012US20120171699 Antibodies for the detection of integrin complexes in ffpe material
07/05/2012US20120171674 Detection of Cells Expressing T1R2 Taste Receptor
07/05/2012US20120171247 Novel proteins within the type e botulinum neurotoxin complex
07/05/2012US20120171242 Modified Antibody
07/05/2012US20120171226 Antibodies to high molecular weight melanoma associated antigen
07/05/2012US20120171225 Diagnostic Method for Predicting the Risk of Cancer Recurrence Based on Histone Macroh2A Isoforms
07/05/2012US20120171224 Anti-ADDL Antibodies and Uses Thereof
07/05/2012US20120171223 High affinity antibodies that neutralize staphylococcus enterotoxin b
07/05/2012US20120171218 Compositions And Methods For The Therapy And Diagnosis Of Influenza
07/05/2012US20120171217 Monoclonal Antibodies Against ANGPTL4
07/05/2012US20120171216 Palmitated monoclonal antibody
07/05/2012US20120171214 Polypeptides
07/05/2012US20120171212 Therapeutic compositions and methods for the prevention of autoimmune diseases
07/05/2012US20120171211 Serum resistance factors of gram positive bacteria
07/05/2012US20120171210 Methods and compositions for inhibiting c-met dimerization and activation
07/05/2012US20120171209 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
07/05/2012US20120171203 Activin receptor-like kinase-1 compositions and methods of use
07/05/2012US20120171196 Monoclonal antibodies that neutralize anthrax toxins
07/05/2012US20120171120 Low affinity blood brain barrier receptor antibodies and uses therefor
07/05/2012US20120171115 Immuno-conjugates and methods for producing them
07/05/2012US20120171114 Anti-cd151 antibodies and their use in the treatment of cancer
07/05/2012CA2834402A1 Clostridium difficile antigens
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 1494